RECORDATI |
Market Closed -
Other stock markets
|
After market 13:40:23 | |||
| 48.52 EUR | -1.30% |
|
48.82 | +0.62% |
| 05-21 | Global markets live: Microsoft, Roche, BMW, Nintendo, Nordson... |  |
| 05-20 | Recordati purchased treasury shares for EUR3.8 million | AN |
ETFs positioned on Recordati
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 306 M€ | +6.59% | - | |
| 0.00% | 39 M€ | +6.13% | - | |
| 0.00% | 105 M€ | +3.84% | - | |
| 0.00% | 17 M€ | +3.49% | - | |
| 0.00% | 34 M€ | +4.01% | - | |
| 0.00% | 234 M€ | +8.58% | - | |
| 0.00% | 54 M€ | +0.73% | - | |
| 0.00% | 8 M€ | +0.94% | - | |
| 0.00% | 1 M€ | 0.00% | - | |
| 0.00% | 29 M€ | -1.89% | - | |
| 0.00% | 146 M€ | -2.42% | - | |
| 0.00% | 25 M€ | -2.62% | - |
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.16
EUR
Average target price
52.24
EUR
Spread / Average Target
+6.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.63% | 10.96B | |
| +39.44% | 723B | |
| +34.28% | 595B | |
| -4.13% | 369B | |
| +20.31% | 332B | |
| +2.91% | 282B | |
| +17.02% | 244B | |
| +9.31% | 208B | |
| -5.07% | 205B | |
| +0.02% | 168B |
- Stock Market
- Equities
- REC Stock
- Funds and ETFs Recordati
